BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 27903229)

  • 1. An Overview of Neolignans of the Genus Piper L.: Isolation Methods and Biological Activities.
    Macedo AL; Dos Santos TCC; Valverde AL; Moreira DL; Vasconcelos TRA
    Mini Rev Med Chem; 2017; 17(8):693-720. PubMed ID: 27903229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lignans from the genus Piper L. and their pharmacological activities: An updated review.
    Fan D; Zhou C; Chen C; Li X; Ma J; Hu Y; Li G; Ruan J; Wu A; Li L; Gong X
    Fitoterapia; 2023 Mar; 165():105403. PubMed ID: 36577457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-inflammatory neolignans from Piper kadsura.
    Lin LC; Shen CC; Shen YC; Tsai TH
    J Nat Prod; 2006 May; 69(5):842-4. PubMed ID: 16724856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neolignans from Piper kadsura and their anti-neuroinflammatory activity.
    Kim KH; Choi JW; Ha SK; Kim SY; Lee KR
    Bioorg Med Chem Lett; 2010 Jan; 20(1):409-12. PubMed ID: 19900811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of in vitro antidiabetic and antioxidant characterizations of Elettaria cardamomum (L.) Maton (Zingiberaceae), Piper cubeba L. f. (Piperaceae), and Plumeria rubra L. (Apocynaceae).
    Ahmed AS; Ahmed Q; Saxena AK; Jamal P
    Pak J Pharm Sci; 2017 Jan; 30(1):113-126. PubMed ID: 28603121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple biological properties of macelignan and its pharmacological implications.
    Paul S; Hwang JK; Kim HY; Jeon WK; Chung C; Han JS
    Arch Pharm Res; 2013 Mar; 36(3):264-72. PubMed ID: 23435944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overview of piperlongumine analogues and their therapeutic potential.
    Zhu P; Qian J; Xu Z; Meng C; Zhu W; Ran F; Zhang W; Zhang Y; Ling Y
    Eur J Med Chem; 2021 Aug; 220():113471. PubMed ID: 33930801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lignans and aromatic glycosides from Piper wallichii and their antithrombotic activities.
    Shi YN; Shi YM; Yang L; Li XC; Zhao JH; Qu Y; Zhu HT; Wang D; Cheng RR; Yang CR; Xu M; Zhang YJ
    J Ethnopharmacol; 2015 Mar; 162():87-96. PubMed ID: 25555357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antioxidant lignans from the roots of Vladimiria muliensis.
    Chen JJ; Wei HB; Xu YZ; Zeng J; Gao K
    Planta Med; 2013 Oct; 79(15):1470-3. PubMed ID: 24046216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neolignans and phenylpropanoids from the roots of Piper taiwanense and their antiplatelet and antitubercular activities.
    Chen S; Huang HY; Cheng MJ; Wu CC; Ishikawa T; Peng CF; Chang HS; Wang CJ; Wong SL; Chen IS
    Phytochemistry; 2013 Sep; 93():203-9. PubMed ID: 23582215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New enantiomeric lignans and new meroterpenoids with nitric oxide release inhibitory activity from Piper puberulum.
    Zheng YK; Wang YQ; Su BJ; Wang HS; Liao HB; Liang D
    Bioorg Chem; 2022 Feb; 119():105522. PubMed ID: 34864279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amides and neolignans from the aerial parts of Piper bonii.
    Ding DD; Wang YH; Chen YH; Mei RQ; Yang J; Luo JF; Li Y; Long CL; Kong Y
    Phytochemistry; 2016 Sep; 129():36-44. PubMed ID: 27452451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Survey of the Chemical Compounds of Piper spp. (Piperaceae) and Their Biological Activities.
    Xiang CP; Shi YN; Liu FF; Li HZ; Zhang YJ; Yang CR; Xu M
    Nat Prod Commun; 2016 Sep; 11(9):1403-1408. PubMed ID: 30807047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New secoisolariciresinol derivatives from Lindera obtusiloba stems and their neuroprotective activities.
    Lee KY; Kim SH; Jeong EJ; Park JH; Kim SH; Kim YC; Sung SH
    Planta Med; 2010 Feb; 76(3):294-7. PubMed ID: 19708005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neolignans from Piper futokadsura and their inhibition of nitric oxide production.
    Konishi T; Konoshima T; Daikonya A; Kitanaka S
    Chem Pharm Bull (Tokyo); 2005 Jan; 53(1):121-4. PubMed ID: 15635246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lignans, an amide and anti-platelet activities from Piper philippinum.
    Chen YC; Liao CH; Chen IS
    Phytochemistry; 2007 Aug; 68(15):2101-11. PubMed ID: 17585974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo anticancer activity of extracts, fractions, and eupomatenoid-5 obtained from Piper regnellii leaves.
    Longato GB; Rizzo LY; Sousa IM; Tinti SV; Possenti A; Figueira GM; Ruiz AL; Foglio MA; de Carvalho JE
    Planta Med; 2011 Sep; 77(13):1482-8. PubMed ID: 21391177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new sesquineolignan and four new neolignans isolated from the leaves of Piper betle, a traditional medicinal plant in Myanmar.
    San TT; Wang YH; Hu DB; Yang J; Zhang DD; Xia MY; Yang XF; Yang YP
    Bioorg Med Chem Lett; 2021 Jan; 31():127682. PubMed ID: 33207281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neolignans and glycosides from the stem bark of Illicium difengpi.
    Fang L; Du D; Ding GZ; Si YK; Yu SS; Liu Y; Wang WJ; Ma SG; Xu S; Qu J; Wang JM; Liu YX
    J Nat Prod; 2010 May; 73(5):818-24. PubMed ID: 20411974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naturally occurring iridoids, secoiridoids and their bioactivity. An updated review, part 3.
    Dinda B; Chowdhury DR; Mohanta BC
    Chem Pharm Bull (Tokyo); 2009 Aug; 57(8):765-96. PubMed ID: 19652401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.